{"": [85, 1071, 0, 1082, 1429, 0, 1440, 1738, 0, 1739, 2418, 0, 2419, 2773, 0, 2774, 3177, 0, 3178, 3516, 0], "COVID-19 AND CARDIOVASCULAR SYSTEM": [3517, 3793, 0], "COVID-19 and Cardiovascular System: Hypothesis of Interaction and Mechanisms of Damage": [3811, 8096, 0], "Myocardial Injury and Myocarditis": [8097, 10392, 0], "Acute Coronary Syndrome": [10393, 11659, 0], "Arrhythmia": [11660, 12627, 0], "Heart Failure": [12628, 14273, 0], "Coagulation Abnormalities": [14274, 17223, 0], "PATHOPHYSIOLOGY": [3794, 17223, 1], "Glucocorticoids": [17527, 18764, 0], "Anticoagulants": [18765, 20713, 0], "COVID-19 Specific Treatments and CV System: Side Effects and Drug-Drug Interaction": [20714, 21200, 0], "Cardiovascular Drugs and COVID-19: Role of RAAS Inhibitors": [21201, 22027, 0], "Therapeutic Antibodies": [22028, 22863, 0], "Vaccine": [22864, 24379, 0], "TREATMENT CONSIDERATIONS": [17224, 24379, 1], "CONCLUSIONS": [24380, 25207, 0]}